Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries

February 18, 2022 |
COVID inequity: In Africa, at-home tests are scarce, costly
Four ways to beat the next pandemic
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...